Global Prostate Cancer Drugs Market Analysis To Grow At CAGR Of 9.21% Over period 2016-2020

“The Report Global Prostate Cancer Drugs Market 2016-2020 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

About Prostate Cancer Market

Prostate cancer is the cancer of prostate gland. According to CDC, it is one of the leading cause of cancer death in men across the races in the US. According to the Urology Care Foundation, globally, one in seven men will be diagnosed with the disease. About one in 35 men die due to prostate cancer. Growth in the prostate can be benign or malignant. Prostate cancer cells spread by breaking away from a prostate tumor. They may travel through blood vessels or lymph vessels and reach other parts of the body. The cells that spread might bind to other tissues, form new tumors, and sometimes damage those tissues as well. When prostate cancer cells spread from their original place to another, the new tumor formed also has the same kind of abnormal cells.

Get Sample copy of this Report @

Technavios analysts forecast the global prostate cancer drugs market to grow at a CAGR of 9.21% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global prostate cancer drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that expected to be launched into the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.

The market is divided into the following segments based on geography:




Technavio’s report, Global Prostate Cancer Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

View Sample PDF @

Key vendors


Astellas Pharma


Johnson & Johnson


Other prominent vendors

Active Biotech

ADC Therapeutics


Advaxis Pharmaceuticals

ANI Pharmaceuticals


Athenex Pharmaceuticals

Bavarian Nordic

Bayer HealthCare

BHR Pharma


Boehringer Ingelheim


Cleveland BioLabs



Dextech Medical


Endo Pharmaceuticals

Ferring Pharmaceutical

Foresee Pharmaceuticals



Innocrin Pharmaceutical

Inspyr Therapeutics

Io Therapeutics

Lidds AB

Merck Group

Myovant Sciences

Northwest Biotherapeutics


Nymox Pharmaceuticals


Oncolytics Biotech



Progenics Pharmaceuticals


Spectrum Pharmaceuticals


Takeda Pharmaceuticals

Teva Pharmaceutical

Tokai Pharmaceuticals

Market driver

Physicians preference toward adopting hormonal therapies

For a full, detailed list, view our report

Market challenge

Presence of alternative treatment approaches

For a full, detailed list, view our report

Market trend

Emergence of targeted therapies and immunotherapies

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.

View Report @

Table of Contents

PART 01: Executive summary


PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Disease overview

Understanding disease

Types of prostate cancer


Key buying criteria

PART 06: Pipeline analysis

PART 07: Market landscape

Global prostate cancer therapeutics market

Five forces analysis

PART 08: Market segmentation by therapy

Hormonal therapy



Targeted therapy

PART 09: Geographical segmentation

Global prostate cancer drugs market by geographical segmentation 2015-2020

Prostate cancer drugs market in Americas

Prostate cancer drugs market in EMEA

Prostate cancer drugs market in APAC

PART 10: Market drivers

Physicians preference toward adopting hormonal therapies

Development of drugs with novel mechanism of action

Availability of large patient pool

PART 11: Impact of drivers

PART 12: Market challenges

Presence of alternative treatment approaches

High cost of drugs

Adverse side-effects of drugs

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

Competitive scenario

PART 16: Key vendor analysis

Johnson & Johnson

Astellas Pharma




Send An Enquiry Request @

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074



Designed by
Powered by
%d bloggers like this: